Indaptus Share Price

Indaptus Share Price

NASDAQ: INDP | Micro Cap | Healthcare
$3.31
-$0.04 (-1.19%) Last updated on 19 Nov, 2026 | 01:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Indaptus Stock Performance

Open
$3.34
Prev. Close
$3.35
Circuit Range
N/A
Day Range
$3.17 - $3.41
Year Range
$0.92 - $5.93
Volume
3,738
Average Traded
$3.31

Indaptus Share Price Today

As of 19 November 2026, Indaptus Therapeutics, Inc.'s share price is $3.31. The stock opened at $3.34, compared to its previous close of $3.35. During today's trading session, Indaptus Therapeutics, Inc.'s share price traded between $3.17 and $3.41, with an average price of $3.29. Over the past 52 weeks, the stock has recorded a high of $5.93 and a low of $0.92. In terms of performance, Indaptus Therapeutics, Inc.'s share price has risen by 87.01% over the last six months and is up 53.95% on a year-on-year basis.

Indaptus Share Price Chart

Line chart of the Indaptus price trend over the selected period. The price fell overall, ranging from 3.17 to 3.42, ending at 3.31.
$3.17$3.41
L
Show Current Price
H

Indaptus Stock Fundamentals & Key Indicators

Market Cap
$3.20M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.10
Revenue (TTM)
$0.00
Return On Equity (TTM)
-135.62%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
39.93%

Indaptus Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.98-$8.11-$2.54-$1.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-172.15%68.68%29.53%

Indaptus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.32-$15.42-$15.02-$20.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-7.68%2.59%-38.81%

Indaptus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.720.930.82
Current Assets9.316.6214.027.24
Total Assets9.317.3414.9228.06
Non Current Liabilities0.00.00.070.0
Current Liabilities6.163.392.773.43
Total Liabilities6.163.392.853.43
Shareholders' Equity3.153.9412.0824.63

Indaptus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-14.82-12.32-13.41-13.08
Investing0.00.017.14-16.43
Financing17.544.750.00.0

Corporate Actions

Split
Ex-date: 27 Jun 2025

Split
Ex-date: 27 Jul 2021

Split
Ex-date: 30 Oct 2020

About Indaptus

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Indaptus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.16
$3.31
+7.29%
Oct 2026
$2.31
$3.08
+33.84%
Sep 2026
$1.14
$2.31
+97.01%
Aug 2026
$1.39
$1.17
-7.87%
Jul 2026
$2.95
$1.27
-57.45%
Jun 2026
$1.86
$2.98
+68.64%
May 2026
$2.66
$1.77
-41.29%
Apr 2026
$1.77
$3.02
+65.66%
Mar 2026
$1.94
$1.82
-7.14%
Feb 2026
$2.12
$1.96
-11.31%
Jan 2026
$2.86
$2.21
-26.33%
Dec 2025
$2.16
$3.00
+39.53%

Indaptus Share Price FAQs